Biedrzycki Barbara A
Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD, USA.
Oncol Nurs Forum. 2011 Sep;38(5):542-52. doi: 10.1188/11.ONF.542-552.
PURPOSE/OBJECTIVES: To describe factors and outcomes related to the decision-making process regarding participation in a cancer clinical trial.
Cross-sectional, descriptive.
Urban, academic, National Cancer Institute-designated comprehensive cancer center in the mid-Atlantic United States.
197 patients with advanced gastrointestinal cancer.
Mailed survey using one investigator-developed instrument, eight instruments used in published research, and a medical record review.
disease context, sociodemographics, hope, quality of life, trust in healthcare system, trust in health professional, preference for research decision control, understanding risks, and information.
decision to accept or decline research participation and satisfaction with this decision.
All of the factors within the Research Decision Making Model together predicted cancer clinical trial participation and satisfaction with this decision. The most frequently preferred decision-making style for research participation was shared (collaborative) (83%).
Multiple factors affect decision making for cancer clinical trial participation and satisfaction with this decision. Shared decision making previously was an unrecognized factor and requires further investigation.
Enhancing the process of research decision making may facilitate an increase in cancer clinical trial enrollment rates. Oncology nurses have unique opportunities as educators and researchers to support shared decision making by those who prefer this method for deciding whether to accept or decline cancer clinical trial participation.
目的/目标:描述与参与癌症临床试验决策过程相关的因素及结果。
横断面描述性研究。
美国大西洋中部地区的一所城市学术型国立癌症研究所指定的综合癌症中心。
197例晚期胃肠道癌患者。
使用一份研究者自行编制的问卷、已发表研究中使用的八份问卷进行邮寄调查,并进行病历审查。
疾病背景、社会人口统计学特征、希望、生活质量、对医疗保健系统的信任、对医疗专业人员的信任、对研究决策控制的偏好、对风险的理解以及信息。
接受或拒绝参与研究的决定以及对该决定的满意度。
研究决策模型中的所有因素共同预测了癌症临床试验的参与情况以及对该决定的满意度。参与研究最常偏好的决策方式是共同(协作)决策(83%)。
多种因素影响参与癌症临床试验的决策以及对该决定的满意度。共同决策以前是一个未被认识到的因素,需要进一步研究。
加强研究决策过程可能有助于提高癌症临床试验的入组率。肿瘤专科护士作为教育者和研究者有独特的机会来支持那些偏好这种方法来决定是否接受或拒绝参与癌症临床试验的人进行共同决策。